Drs Philip Oldfield and Maria Gutschi have written an analysis of Pfizer’s COVID-19 licence application submission. Many flaws and omissions have been identified with the application and review process which raise concerns about the product’s safety and effectiveness. The authors request full transparency from Health Canada as to the approval process of the novel gene therapy vaccines.
